title: Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
authors.affiliation: Department of Surgery, University of Pittsburgh, PA 15213.
authors.forename: K M
authors.initials: KM
authors.lastname: Abu-Elmagd
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: R
authors.initials: R
authors.lastname: Venkataramanan
authors.forename: V S
authors.initials: VS
authors.lastname: Warty
authors.forename: W
authors.initials: W
authors.lastname: Shannon
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
mesh_terms: D001663:Bilirubin / Q000097:blood; D004334:Drug Administration Schedule; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
chemical_list: D013256:Steroids; D001663:Bilirubin; D016559:Tacrolimus